K. Al-Rasadi

发表

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

J. Car, H. Schunkert, S. Yamashita, 2018, Atherosclerosis.

Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update.

M. Zubaid, W. Almahmeed, K. Sulaiman, 2021, Atherosclerosis.

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

R. Santos, S. Goh, M. Rizzo, 2021, Frontiers in Cardiovascular Medicine.

Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman

D. Mikhailidis, I. Al-Zakwani, K. Sulaiman, 2011, Current medical research and opinion.

Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).

Z. Awan, J. Genest, I. Ruel, 2008, The American journal of cardiology.

Genetic Lipoprotein Disorders and Cardiovascular Disease

I. Iatan, Z. Dastani, Z. Awan, 2010 .

Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)

W. Almahmeed, R. Santos, D. Blom, 2018, European journal of preventive cardiology.

Novel Therapeutical Approaches to Managing Atherosclerotic Risk

M. Banach, M. Rizzo, A. Rizvi, 2021, International journal of molecular sciences.

Correlation of Iron Overload and Glomerular Filtration Rate Estimated by Cystatin C in Patients with β-Thalassemia Major

S. Bhandari, S. Daar, M. Al-Khabori, 2014, Hemoglobin.

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

J. Car, H. Schunkert, S. Yamashita, 2016, Atherosclerosis. Supplements.

Benefits of lowering cholesterol in chronic kidney disease

Yajnavalka Banerjee, K. Al-Rasadi, 2011, The Lancet.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Familial hypercholesterolaemia: a global call to arms

J. Car, H. Schunkert, C. Aguilar-Salinas, 2015 .

PHYSICAL FITNESS ATTRIBUTES, VITAMIN D, DEPRESSION, AND BMD IN OMANI’S CHILDREN

I. Al-Zakwani, H. Kilani, K. Al-Rasadi, 2013 .

Saphenous vein graft vs. radial artery graft searching for the best second coronary artery bypass graft.

H. Al-Sabti, K. Al-Hashmi, Yajnavalka Banerjee, 2013, Journal of the Saudi Heart Association.

Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.

Karna Shah, Yajnavalka Banerjee, K. Al-Rasadi, 2012, The New England journal of medicine.

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol

I. Al-Zakwani, F. Baslaib, H. Amin, 2022, Oman medical journal.

A Comprehensive Neuropsychological Study of Familial Hypercholesterolemia and Its Relationship with Psychosocial Functioning: A Biopsychosocial Approach

M. Chan, S. Al-Adawi, K. Al-Rasadi, 2022, Brain sciences.

Treatment options for managing atherogenic dyslipidemia and fatty liver disease

M. Rizzo, G. Montalto, K. Al-Rasadi, 2014, Expert opinion on pharmacotherapy.

The Effects of Anti-Diabetic Drugs on LDL Subclasses: Any Role for Colesevelam?

D. Mikhailidis, M. Rizzo, K. Al-Rasadi, 2014, Cardiovascular Drugs and Therapy.

Will β-Blockers Live up to the Maxim of Sir James Black, Their Creator?

Yajnavalka Banerjee, K. Al-Rasadi, Khalid Al-Waili, 2012, Angiology.

Drug Evaluation: The Combination of Fenofibrate and Simvastatin for the Treatment of Dyslipidemia: When and for Whom?

M. Banach, D. Mikhailidis, M. Rizzo, 2015 .

The Genetic Spectrum of Familial Hypertriglyceridemia in Oman

F. Zadjali, A. Al-Maawali, A. Al-Mujaini, 2022, Frontiers in Genetics.

Statin of Preference to Treat Dyslipidaemia in Patients with Renal Dysfunction: Cues from (SATURN).

R. Bayoumi, Yajnavalka Banerjee, K. Al-Rasadi, 2012, Sultan Qaboos University medical journal.

World Heart Federation Cholesterol Roadmap.

S. Yusuf, G. Watts, P. Perel, 2017, Global heart.

Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?

R. Santos, M. Rizzo, Yajnavalka Banerjee, 2016, Atherosclerosis.

Healthcare resource utilization in patients on lipid-lowering therapies outside Western Europe and North America: findings of the cross-sectional observational International ChoLesterol management Practice Study (ICLPS)

I. Al-Zakwani, L. Annemans, N. Danchin, 2020, Lipids in Health and Disease.

Accuracy of ultrasound-guided fine-needle aspiration cytology for diagnosis of carcinoma in patients with multinodular goiter

I. Al-Zakwani, K. Al-Rasadi, H. Farhan, 2011, Indian journal of endocrinology and metabolism.

Treatment of low high-density lipoprotein cholesterol

Z. Awan, J. Genest, K. Al-Rasadi, 2008 .

White coat hypertension and masked hypertension among omani patients attending a tertiary hospital for ambulatory blood pressure monitoring.

D. Jaju, M. Al-Abri, H. Al-Sabti, 2015, Oman medical journal.

Familial hypercholesterolaemia

D. Nair, K. Al-Rasadi, M. Sharifi, 2014, Current opinion in cardiology.

Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study

I. Al-Zakwani, R. Santos, A. Shehab, 2018, Lipids in Health and Disease.

Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study.

W. Almahmeed, R. Santos, D. Blom, 2019, Journal of clinical lipidology.

Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study

I. Al-Zakwani, R. Santos, A. Shehab, 2018, Lipids in Health and Disease.

Incretins, Pregnancy, and Gestational Diabetes.

K. Al-Hashmi, M. Rizzo, A. Rizvi, 2016, Current pharmaceutical biotechnology.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.